New pill tested for hard-to-treat cancers
Disease control
Ongoing
This early-stage study tests a new tablet called BB3008 in about 42 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see how the body processes the drug. Participants take the tablet by m…
Phase: PHASE1 • Sponsor: Broadenbio Ltd., Co. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC